Juping Zhao Kun Dai Jialing Xie Chen Fang Na Chen Jun Dai Danfeng Xu
10.3389/fphar.2022.927299
Front Pharmacol
2022 Aug 11;13:927299.
pd-1 ptprd-mutation xp112 translocation renal cell carcinoma immunotherapy tyrosine kinase inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/36034832/
Case Reports
PMC9403306
36034832
Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report
2022